Catalyst Wire Dossier Catalyst Wire Dossier

VEGF Trap-Eye (aflibercept)

aflibercept · Regeneron Pharmaceuticals; Sanofi
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VEGF Trap-Eye (aflibercept), covering 2014-04-01 to 2016-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy [Phase 4]

See pricing